RxDoctor Payments Data

Michael Noparstak, DO

Dermatology · Ellsworth, MENPI 1881057594

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.8% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $505 and has fallen 78.6% since, to $108 in 2024.

$1,545in general payments, 2019–2025

Across 54 payments — averaging $28.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Pfizer$207
  • Johnson & Johnson$183
  • Lilly USA, LLC$158
  • Regeneron Healthcare Solutions, Inc.$127
  • Sanofi-aventis U.S. LLC$122
  • plus $406 from 8 others

What the payments were for

  • Food & beverage$1,46595%
  • Education$805%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,545 in reported general payments places this provider in the 70th percentile of 46 dermatology providers in Maine.

See all dermatology providers in Maine

Medicare billing

Part B allowed, 2024
$685,250
Medicare patients
1,131
Services billed
6,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab18$119,952
OtezlaApremilast12$54,364
Clobetasol Propionate178$8,921
Ketoconazole142$2,995
Triamcinolone Acetonide93$1,650
Doxycycline Hyclate43$1,524
Hydrocortisone65$1,299
Mometasone Furoate50$998
Fluorouracil16$994
Metronidazole19$799
Fluocinonide12$798
Dutasteride28$408
ValacyclovirValacyclovir Hcl12$248
Fluconazole12$241
Minoxidil12$174

Paid to pharmacies, not to this prescriber.

Other dermatology in Ellsworth

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →